WST Exercise Disclosure
Favorite Annette F · SEC Form 4 · Filed Sep 15, 2026
Exercise
Calculated transaction value
$0
Favorite Annette F Sr. VP & Chief HR Officer
WST
Transaction date
Sep 11, 2026
Public filing date
Sep 15, 2026
Filing lag
Filed 4 days later
WST daily price context
Close on/before transaction
$346.23
Sep 11, 2026
Close before public filing
$355.2
Sep 14, 2026
Return since public filing
+3.21%
Through Sep 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 2,500 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0000105770-26-000110
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$3.35M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| West Pharmaceutical Services Inc WST | Exercise | Sep 15, 2026 | $0 |
| West Pharmaceutical Services Inc WST | Exercise | Sep 15, 2026 | $226.25K |
| West Pharmaceutical Services Inc WST | Sale | Sep 15, 2026 | $921.26K |
| West Pharmaceutical Services Inc WST | Exercise | Sep 14, 2026 | $0 |
| West Pharmaceutical Services Inc WST | Exercise | Sep 14, 2026 | $224.1K |
| West Pharmaceutical Services Inc WST | Sale | Sep 14, 2026 | $887.5K |
| West Pharmaceutical Services Inc WST | Exercise | Sep 11, 2026 | $224.1K |
| West Pharmaceutical Services Inc WST | Sale | Sep 11, 2026 | $862.5K |
| West Pharmaceutical Services Inc WST Current | Exercise | Sep 11, 2026 | $0 |